{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T09:53:06Z","timestamp":1762595586157,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019370","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","award":["SFRH\/BD\/72862\/2010","CEECIND\/01006\/2017","PTDC\/SAU-GMG\/105344\/2008"],"award-info":[{"award-number":["SFRH\/BD\/72862\/2010","CEECIND\/01006\/2017","PTDC\/SAU-GMG\/105344\/2008"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbalip.2025.159657","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T12:00:03Z","timestamp":1751976003000},"page":"159657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["LIMP-2 deficiency-associated glycolipid abnormalities in mice"],"prefix":"10.1016","volume":"1870","author":[{"given":"Paulo","family":"Gaspar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 R.A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertjan","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Mirzaian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Gijbels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roelof","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"van Roomen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman S.","family":"Overkleeft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schwake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Heybrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carmo","family":"Mac\u00e1rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Saftig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes M.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2025.159657_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Diseases","article-title":"Glucosylceramide lipidosis-Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bbalip.2025.159657_bb0010","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2025.159657_bb0015","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/hmg\/ddn124","article-title":"A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome","volume":"17","author":"Balreira","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2025.159657_bb0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ajhg.2007.12.019","article-title":"Array-based gene discovery with three unrelated subjects shows SCARB2\/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis","volume":"82","author":"Berkovic","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2025.159657_bb0025","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1242\/jcs.00075","article-title":"A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology","volume":"115","author":"Kuronita","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbalip.2025.159657_bb0030","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1074\/jbc.273.9.4855","article-title":"Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif","volume":"273","author":"Crombie","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2025.159657_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00032","article-title":"Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases","volume":"3","author":"Yamayoshi","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbalip.2025.159657_bb0040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nm.1992","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"Yamayoshi","year":"2009","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159657_bb0045","article-title":"Cellular receptors for enterovirus 762 A71","volume":"27","author":"Kobayashi","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbalip.2025.159657_bb0050","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/nan.12057","article-title":"Progressive myoclonus epilepsy: Extraneuronal brown pigment deposition and system neurodegeneration in the brains of Japanese patients with novel SCARB2 mutations","volume":"40","author":"Fu","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbalip.2025.159657_bb0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.21765","article-title":"SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure","volume":"66","author":"Dibbens","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbalip.2025.159657_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2377-11-134","article-title":"Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features","volume":"11","author":"Hopfner","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bbalip.2025.159657_bb0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jns.2014.01.022","article-title":"A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced \u03b2-glucocerebrosidase activity","volume":"339","author":"Zeigler","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbalip.2025.159657_bb0070","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.seizure.2011.06.018","article-title":"Progressive myoclonus epilepsy with nephropathy C1q due to SCARB2\/LIMP-2 deficiency: clinical report of two siblings","volume":"20","author":"Chaves","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.bbalip.2025.159657_bb0075","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.25738","article-title":"A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure","volume":"29","author":"Perandones","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbalip.2025.159657_bb0080","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/mds.25114","article-title":"A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure","volume":"27","author":"Guerrero-L\u00f3pez","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbalip.2025.159657_bb0085","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.25296","article-title":"A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy","volume":"28","author":"Higashiyama","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbalip.2025.159657_bb0090","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mds.25083","article-title":"A case of severe hearing loss in action myoclonus renal failure syndrome resulting from mutation in SCARB2","volume":"27","author":"Perandones","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbalip.2025.159657_bb0095","doi-asserted-by":"crossref","first-page":"F1437","DOI":"10.1152\/ajprenal.00015.2011","article-title":"Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2\/Limp-2","volume":"300","author":"Desmond","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbalip.2025.159657_bb0100","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1111\/j.1528-1167.2011.03307.x","article-title":"Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations","volume":"52","author":"Rubboli","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbalip.2025.159657_bb0105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbalip.2025.159657_bb0110","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/S0021-9258(17)37676-7","article-title":"Lysosomal targeting of Limp II membrane glycoprotein requires a novel Leu-Ile motif at a particular position in its cytoplasmic tail","volume":"269","author":"Ogata","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2025.159657_bb0115","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1016\/S0021-9258(17)37418-5","article-title":"The residues Leu(Ile)475-Ile(Leu, Val, Ala)476, contained in the extended carboxyl cytoplasmic tail, are critical for targeting of the resident lysosomal membrane protein LIMP II to lysosomes","volume":"269","author":"Sandoval","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2025.159657_bb0120","doi-asserted-by":"crossref","first-page":"16269","DOI":"10.1016\/S0021-9258(18)55288-1","article-title":"Targeting of lysosomal integral membrane protein LIMP II. The tyrosine-lacking carboxyl cytoplasmic tail of LIMP II is sufficient for direct targeting to lysosomes","volume":"266","author":"Vega","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2025.159657_bb0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nature12684","article-title":"Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36","volume":"504","author":"Neculai","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2025.159657_bb0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/hmg\/ddp523","article-title":"Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand \u03b2-glucocerebrosidase","volume":"19","author":"Blanz","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2025.159657_bb0135","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1514005113","article-title":"Characterization of the complex formed by \u03b2-glucocerebrosidase and the lysosomal integral membrane protein type-2","author":"Zunke","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2025.159657_bb0140","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1600-0854.2012.01372.x","article-title":"A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand \u03b2-glucocerebrosidase","volume":"13","author":"Zachos","year":"2012","journal-title":"Traffic"},{"key":"10.1016\/j.bbalip.2025.159657_bb0145","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","article-title":"LIMP-2 expression is critical for \u03b2-glucocerebrosidase activity and -synuclein clearance","volume":"111","author":"Rothaug","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbalip.2025.159657_bb0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1194\/jlr.M043802","article-title":"Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis","volume":"55","author":"Gaspar","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2025.159657_bb0155","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2025.159657_bb0160","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41467-017-02044-8","article-title":"Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies","volume":"8","author":"Conrad","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2025.159657_bb0165","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1038\/s41467-019-11425-0","article-title":"Lysosomal integral membrane protein-2 (LIMP-2\/SCARB2) is involved in lysosomal cholesterol export","volume":"10","author":"Heybrock","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2025.159657_bb0170","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tcb.2020.02.007","article-title":"Cholesterol handling in lysosomes and beyond","volume":"30","author":"Meng","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159657_bb0175","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1038\/s41467-025-58340-1","article-title":"Cryo-TEM structure of \u03b2-glucocerebrosidase in complex with its its transporter LIMP-2","volume":"16","author":"Dobert","year":"2025","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.bbalip.2025.159657_bb0180","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1021\/jacs.7b13003","article-title":"\u0392-Glucocerebrosidase modulators promote dimerization of \u03b2-Glucocerebrosidase and reveal an allosteric binding site","volume":"140","author":"Zheng","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"22","key":"10.1016\/j.bbalip.2025.159657_bb0185","doi-asserted-by":"crossref","first-page":"jcs261810","DOI":"10.1242\/jcs.261810","article-title":"The lysosomal lipid transporter LIMP-2 is part of lysosome-ER STARD3-VAPB-dependent contact sites","volume":"137","author":"Rudnik","year":"2024","journal-title":"J. Cell Sci."},{"issue":"25","key":"10.1016\/j.bbalip.2025.159657_bb0190","first-page":"e2401641","article-title":"Activation and purification of \u00df-glucocerebrosidase by exploiting its transporter LIM\u2013-2 - implications for novel treatment strategies in Gau\u2019her\u2019s and Parki\u2019son\u2019s disease","volume":"11","author":"Dobert","year":"2024","journal-title":"Adv. Sci. (Weinh.)."},{"issue":"21","key":"10.1016\/j.bbalip.2025.159657_bb0195","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.3390\/ijms252111443","article-title":"Investigating the impact of the Parki\u2019son\u2019s-associated GBA1 E326K mutation on \u03b2-glucocerebrosidase dimerization and interactome dynamics through an in silico approach","volume":"25","author":"Pietrafesa","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2025.159657_bb0200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/hmg\/ddg062","article-title":"LIMP-2\/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice","volume":"12","author":"Gamp","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2025.159657_bb0205","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nchembio.466","article-title":"Ultrasensitive in situ visualization of active glucocerebrosidase molecules","volume":"6","author":"Witte","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbalip.2025.159657_bb0210","doi-asserted-by":"crossref","first-page":"35351","DOI":"10.1074\/jbc.M114.593376","article-title":"A sensitive gel-based method combining distinct cyclophellitol-based probes for the identification of acid\/base residues in human retaining \u03b2-glucosidases","volume":"289","author":"Kallemeijn","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2025.159657_bb0215","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbalip.2025.159657_bb0220","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases","volume":"590","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2025.159657_bb0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1194\/jlr.M064923","article-title":"Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular \u03b2-glucosidases","volume":"57","author":"Marques","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2025.159657_bb0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/MCB.01143-09","article-title":"Impaired lysosomal trimming of N-linked oligosaccharides leads to hyperglycosylation of native lysosomal proteins in mice with -mannosidosis","volume":"30","author":"Damme","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2025.159657_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140097","article-title":"Accuracy and reproducibility in quantification of plasma protein concentrations by mass spectrometry without the use of isotopic standards","volume":"10","author":"Kramer","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bbalip.2025.159657_bb0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1432-1033.1985.tb09058.x","article-title":"The occurrence of two immunologically distinguishable \u03b2-glucocerebrosidases in human spleen","volume":"150","author":"Aerts","year":"1985","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbalip.2025.159657_bb0245","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1373\/clinchem.2006.079012","article-title":"HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma","volume":"53","author":"Groener","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbalip.2025.159657_bb0250","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bcmd.2015.01.006","article-title":"Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard","volume":"54","author":"Mirzaian","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbalip.2025.159657_bb0255","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2025.159657_bb0260","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1194\/jlr.M057232","article-title":"Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry","volume":"56","author":"Mirzaian","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2025.159657_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135889","article-title":"Reducing GBA2 activity ameliorates neuropathology in Niemann-pick type C mice","volume":"10","author":"Marques","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159657_bb0270","doi-asserted-by":"crossref","first-page":"e0147208","DOI":"10.1371\/journal.pone.0147208","article-title":"Gpnmb is a potential marker for the visceral pathology in Niemann-Pick type C disease","volume":"11","author":"Marques","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2025.159657_bb0280","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/mt.2015.16","article-title":"Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice","volume":"23","author":"Dahl","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbalip.2025.159657_bb0285","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2025.159657_bb0295","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","article-title":"Glucocerebrosidase is shaking up the synucleinopathies","volume":"137","author":"Siebert","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bbalip.2025.159657_bb0300","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mds.24886","article-title":"Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson\u2019s disease","volume":"27","author":"Michelakakis","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbalip.2025.159657_bb0305","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2013.01.012","article-title":"Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data","volume":"108","author":"Maniwang","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159657_bb0310","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13041-020-00712-3","article-title":"Fibroblasts from idiopathic Parki\u2019son\u2019s disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2","volume":"14","author":"Thomas","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbalip.2025.159657_bb0315","doi-asserted-by":"crossref","first-page":"749109","DOI":"10.3389\/fnagi.2021.749109","article-title":"The association between lysosomal storage disorder genes and Parki\u2019son\u2019s disease: a large cohort study in Chinese mainland population","volume":"13","author":"Zhao","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159657_bb0320","doi-asserted-by":"crossref","first-page":"e1010760","DOI":"10.1371\/journal.pgen.1010760","article-title":"Functional screening of lysosomal storage disorder genes identifies modifiers of alpha-synuclein neurotoxicity","volume":"19","author":"Yu","year":"2023","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159657_bb0325","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/mds.28396","article-title":"The role of cholesterol in \u03b1-synuclein and Lewy body pathology in GBA1 Parkinson\u2019s disease","volume":"36","author":"Garc\u00eda-Sanz","year":"2021","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159657_bb0330","doi-asserted-by":"crossref","first-page":"26","DOI":"10.32607\/20758251-2017-9-1-26-37","article-title":"Cholesterol in the pathogenesis of Alzheimer\u2019s, Parkinson\u2019s diseases and autism: link to synaptic dysfunction","volume":"9","author":"Petrov","year":"2017","journal-title":"Acta Nat."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198125000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198125000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T09:50:53Z","timestamp":1762595453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198125000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1388198125000654"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2025.159657","relation":{},"ISSN":["1388-1981"],"issn-type":[{"type":"print","value":"1388-1981"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LIMP-2 deficiency-associated glycolipid abnormalities in mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2025.159657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"159657"}}